3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, Mantle-Cell
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Biphenotypic, Acute
2
Down Syndrome
2
Blast Crisis
2
Renal Pelvis and Ureter Urothelial Carcinoma
1
Osteosarcoma
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Blastic Plasmacytoid Dendritic Cell Neoplasm
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Cyclophosphamide
13
Rituximab
11
obinutuzumab
6
fludarabine phosphate
6
Prednisone
6
Magnetic Resonance Spectroscopy
6
ibrutinib
5
fludarabine
5
X-Rays
5
Specimen Handling
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
5
Melphalan
5
Lenalidomide
5
Etoposide
5
Doxorubicin
5
Biopsy
5
tocilizumab
4
Whole-Body Irradiation
4
venetoclax
3
polatuzumab vedotin
3
glofitamab
3
acalabrutinib
3
Vincristine
3
Mycophenolic Acid
3
Leukapheresis
3
Filgrastim
3
Cytarabine
3
Cyclosporine
3
Busulfan
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Non-Hodgkin
×
merphos
×
30 days
×
Clear all
No trials found.